Alessandro Guidotti

Neurosteroids (allopregnanolone) and alcohol use disorder: From mechanisms to potential pharmacotherapy

Corticosterone induces discrete epigenetic signatures in the dorsal and ventral hippocampus that depend upon sex and genotype: focus on methylated Nr3c1 gene

Altered Expression and In Vivo Activity of mGlu5 Variant a Receptors inthe Striatum of BTBR Mice: Novel Insights Into the Pathophysiology ofAdult Idiopathic Forms of Autism Spectrum Disorders

Concordance of Immune-Related Markers in Lymphocytes and Prefrontal Cortex in Schizophrenia

Gene expression of methylation cycle and related genes in lymphocytes and brain of patients with schizophrenia and non-psychotic controls

Allopregnanolone: From molecular pathophysiology to therapeutics. A historical perspective

Epigenetic Regulation of GABAergic Neurotransmission and Neurosteroid Biosynthesis in Alcohol Use Disorder

Genome-wide methylation in alcohol use disorder subjects: implications for an epigenetic regulation of the cortico-limbic glucocorticoid receptors (NR3C1)

Prenatal stress leads to chromatin and synaptic remodeling and excessive alcohol intake comorbid with anxiety-like behaviors in adult offspring

N-Phthalyl-l-Tryptophan (RG108), like Clozapine (CLO), Induces Chromatin Remodeling in Brains of Prenatally Stressed Mice

Epigenetic Alterations in Prenatal Stress Mice as an Endophenotype Model for Schizophrenia: Role of Metabotropic Glutamate 2/3 Receptors

Potential role for histone deacetylation in chronic diazepam‐induced downregulation of α1‐<scp>GABA_A</scp>receptor subunit expression

Epigenetic regulation of <i>RELN</i> and <i>GAD1</i> in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects

Chronic Alcohol Exposure Differentially Alters One-Carbon Metabolism in Rat Liver and Brain

Emerging Role of One-Carbon Metabolism and DNA Methylation Enrichment on δ-Containing GABAA Receptor Expression in the Cerebellum of Subjects with Alcohol Use Disorders (AUD)

Behavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugs

Epigenetic RELN Dysfunction in Schizophrenia and Related Neuropsychiatric Disorders

Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial

Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review

Role of Growth Arrest and <scp>DNA</scp> Damage‐Inducible, Beta in Alcohol‐Drinking Behaviors

Maternal immune activation induces<i>GAD1</i>and<i>GAD2</i>promoter remodeling in the offspring prefrontal cortex

Gadd45b and <i>N</i> -Methyl- <scp>d</scp> -Aspartate Induced DNA Demethylation in Postmitotic Neurons

Merging Data from Genetic and Epigenetic Approaches to Better Understand Autistic Spectrum Disorder

Brain-Derived Neurotrophic Factor Epigenetic Modifications Associated with Schizophrenia-like Phenotype Induced by Prenatal Stress in Mice

Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum

DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients

5α-reductase type I expression is downregulated in the prefrontal cortex/Brodmann’s area 9 (BA9) of depressed patients

DNA methylation and demethylation as targets for antipsychotic therapy

DNA methylation and demethylation as targets for antipsychotic therapy.

Epigenetic Mechanisms in Autism Spectrum Disorder